作为2型糖尿病老年人治疗策略的皮拉提运动计划:对功能能力和血糖的影响
Beatriz Ruiz-Ariza1, Fidel Hita-Contreras1, Agustín Aibar-Almazán1
1Department of Health Sciences, Faculty of Health Sciences, University of Jaén, 23071 Jaén, Spain.
Healthcare (Basel, Switzerland)
|May 14, 2025
概括
皮拉提显著改善了2型糖尿病的老年人血糖控制和身体功能. 这种为期12周的干预措施增强了力量,平衡和灵活性,支持其作为非药物治疗的使用.
科学领域:
- 老年学是指老年学的学科.
- 运动生理学 运动生理学
- 内分泌学 在内分泌学.
背景情况:
- 患有2型糖尿病 (T2DM) 的老年人经常面临身体功能和代谢调节方面的挑战.
- 身体功能受损和代谢控制是老年T2DM患者常见的并发症.
研究的目的:
- 评估12周 Pilates干预对T2DM老年人血糖水平和身体功能的影响.
- 评估Pilates在改善老年T2DM患者的血糖控制和身体能力方面的有效性.
主要方法:
- 进行了一项随机对照试验,涉及104名2型糖尿病的老年人.
- 参与者被分配到对照组或Pilates组 (12周每周2次).
- 关键结果包括血糖,手握强度,步行速度,平衡和灵活性,在干预前和后进行测量.
主要成果:
- 与对照组相比,Pilates组在血糖度方面表现出显著的改善.
- 在掌握力,步行速度,平衡 (伯格平衡量级) 和灵活性 (椅子坐和伸缩测试,背部划痕测试) 中观察到统计学上显著的改善.
结论:
- 一个为期12周的Pilates计划是T2DM的老年人安全有效的非药物干预.
- 普拉提运动对血糖控制,肌肉力量,步行速度,平衡和灵活性产生积极影响,促进了这一群体的整体健康.
相关概念视频
Carbohydrate Metabolism
10.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.6K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications
487
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
487
Dipeptidyl Peptidase 4 Inhibitors
139
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
139
Oral Hypoglycemic Agents: Biguanides and Glitazones
142
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
142
Diabetes: Management and Pharmacotherapy
214
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
214


